Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA5A | P35218 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1471796 | 0.76 | — | — | |
| SCHEMBL11714749 | 0.74 | TSHR (0.46) | CA1CA2CA5ACA9TSHR | |
| SCHEMBL7645201 | 0.70 | CA1 (0.50) | CA1CA2CA5ACA9TSHR | |
| SCHEMBL10639581 | 0.69 | — | — | |
| SCHEMBL12909303 | 0.69 | ESR1 (0.37) | TSHRALDH1A1 | |
| SCHEMBL18316472 | 0.68 | CA1 (0.64) | CA1CA2CA5ACA9TSHR | |
| SCHEMBL26193589 | 0.68 | CA1 (0.52) | CA1CA2CA5ACA9TSHR | |
| SCHEMBL3873862 | 0.67 | PTPN1 (0.49) | CA1CA2CA5ACA9TSHR | |
| SCHEMBL6727215 | 0.67 | — | — | |
| SCHEMBL1274760 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7993797-B2 | Chemically modified catalyzed support particles for electrochemical cells | GM Global Technology Operations LLC (US) | 2011-08-09 | — | — | US | disclosed |
| US-20100028745-A1 | Chemically modified catalyzed support particles for electrochemical cells | GM GLOBAL TECHNOLOGY OPERATIONS, INC. (US) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028745-A1 | Chemically modified catalyzed support particles for electrochemical cells | PEF1, PXMP4, EPCAM | CA1 229/4885CA2 461/4885CA5A 493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.